# NIH Reporter #1R01CA304003-01A1

Movement is medicine in multiple myeloma: elucidating exercise-mediated immune and metabolic biomarkers that predict treatment response in the bone marrow tumor microenvironment

**Recipient:** ROSWELL PARK CANCER INSTITUTE CORP

**Award Amount:** $718,490.00
**Ceiling:** $718,490.00

**Awarded:** September 16, 2026

**Identifier:** 1R01CA304003-01A1

NIH/NCI awarded a research project to study exercise-mediated immune and metabolic biomarkers in multiple myeloma to predict treatment response in the bone marrow tumor microenvironment.

### Description

This is a research project funded by the NIH/NCI focusing on exercise interventions in multiple myeloma patients, with a detailed study plan involving immune and metabolomic biomarkers, machine learning, and clinical trials.

[View original record](https://reporter.nih.gov/search/IgE1H2ioLUOz0qmA4MDg0Q/project-details/11366341)